Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover advanced catalytic methods for pyrimidylcyclopentane intermediates. Enhance purity and reduce costs in AKT inhibitor manufacturing with our scalable solutions.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113444702B reveals high-efficiency OYE1 mutant for Brivaracetam intermediate production, offering superior conversion and ee values for scalable API manufacturing.
Patent CN105624214A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction in agrochemical intermediate manufacturing without heavy metals.
Patent CN114940964B reveals efficient UDCA production. Reduced costs and high purity for pharmaceutical supply chains.
Improved transaminase catalysis for sitagliptin reduces solvent use and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.